Grifols SA (GRFS)
6.30
+0.02
(+0.32%)
USD |
NASDAQ |
Apr 22, 16:00
6.30
0.00 (0.00%)
After-Hours: 20:00
Grifols Net Income (TTM): 211.12M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 211.12M |
September 30, 2023 | 195.70M |
June 30, 2023 | 227.10M |
December 31, 2022 | 326.60M |
September 30, 2022 | 462.65M |
June 30, 2022 | 576.18M |
June 30, 2021 | 792.69M |
March 31, 2021 | 662.82M |
December 31, 2020 | 711.93M |
September 30, 2020 | 776.91M |
June 30, 2020 | 615.97M |
March 31, 2020 | 774.67M |
December 31, 2019 | 698.91M |
September 30, 2019 | 621.95M |
June 30, 2019 | 643.77M |
March 31, 2019 | 659.61M |
December 31, 2018 | 705.87M |
September 30, 2018 | 831.38M |
June 30, 2018 | 838.69M |
March 31, 2018 | 787.35M |
December 31, 2017 | 753.91M |
September 30, 2017 | 632.31M |
June 30, 2017 | 609.48M |
March 31, 2017 | 608.45M |
Date | Value |
---|---|
December 31, 2016 | 603.88M |
September 30, 2016 | 596.35M |
June 30, 2016 | 593.96M |
March 31, 2016 | 583.68M |
December 31, 2015 | 590.49M |
September 30, 2015 | 611.61M |
June 30, 2015 | 607.18M |
March 31, 2015 | 602.65M |
December 31, 2014 | 623.40M |
September 30, 2014 | 566.34M |
June 30, 2014 | 526.72M |
March 31, 2014 | 504.17M |
December 31, 2013 | 458.58M |
September 30, 2013 | 428.67M |
June 30, 2013 | 396.84M |
March 31, 2013 | 361.64M |
December 31, 2012 | 330.04M |
September 30, 2012 | 261.84M |
June 30, 2012 | 216.68M |
March 31, 2012 | 111.26M |
December 31, 2011 | 68.75M |
September 30, 2011 | 85.08M |
June 30, 2011 | 89.95M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
195.70M
Minimum
Sep 2023
792.69M
Maximum
Jun 2021
553.27M
Average
621.95M
Median
Sep 2019
Net Income (TTM) Benchmarks
DBV Technologies SA | -72.73M |
Adaptimmune Therapeutics PLC | -113.87M |
Biodexa Pharmaceuticals Plc | -8.826M |
NuCana PLC | -34.32M |
Autolus Therapeutics PLC | -208.38M |